Samantha McLemore - Patient Capital Management
Holding/activity history for Crocs, Inc. (CROX)
← All CROX superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 842,842 | 2.61 | Add 11.08% | 0.26 | $75.13–101.59 · VW $86.66i | $69,972,795 | SEC |
| 2025 Q4 | 758,797 | 2.50 | Add 28.87% | 0.56 | $73.21–92.12 · VW $83.49i | $64,892,321 | SEC |
| 2025 Q3 | 588,794 | 1.97 | Add 16.97% | 0.29 | $73.76–110.18 · VW $89.59i | $49,193,697 | SEC |
| 2025 Q2 | 503,378 | 2.30 | Reduce 1.57% | 0.04 | $86.11–122.84 · VW $101.76i | $50,982,102 | SEC |
| 2025 Q1 | 511,399 | 2.79 | Add 14.86% | 0.36 | $88.25–115.08 · VW $102.94i | $54,310,622 | SEC |
| 2024 Q4 | 445,227 | 2.25 | Add 16.87% | 0.32 | $95.05–144.44 · VW $111.30i | $48,765,674 | SEC |
| 2024 Q3 | 380,969 | 2.71 | Add 0.38% | 0.01 | $112.50–151.13 · VW $136.71i | $55,168,167 | SEC |
| 2024 Q2 | 379,509 | 2.94 | Reduce 9.44% | 0.28 | $118.60–165.32 · VW $142.50i | $55,385,499 | SEC |
| 2024 Q1 | 419,057 | 2.93 | Reduce 0.70% | 0.01 | $85.71–144.89 · VW $112.74i | $60,260,447 | SEC |
| 2023 Q4 | 422,010 | 2.09 | Buy | 2.09 | $74.00–110.90 · VW $93.89i | $39,419,951 | SEC |
Price snapshot:
Current price$130.46
Avg. buy price$92.07
+/- since buy41.70%
52-week low$73.21
52-week high$134.77